Literature DB >> 6980217

In-vitro bactericidal synergism of rifampicin and trimethoprim and implications for treatment of carriers of Haemophilus influenzae.

L K McDougal, C Thornsberry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6980217     DOI： 10.1093/jac/9.5.369

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  In vitro interactions between rifampin and ampicillin or chloramphenicol against Haemophilus influenzae.

Authors:  T Jadavji; C G Prober; R Cheung
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

2.  Rifampicin in non-tuberculous infections.

Authors:  A J Davies; D A Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-07

3.  Rifampin alone or with trimethoprim for contacts of children with Haemophilus influenzae type b infections.

Authors:  T Jadavji; R Cheung; R M Bannatyne; C G Prober
Journal:  CMAJ       Date:  1986-08-15       Impact factor: 8.262

Review 4.  Antibiotic resistance in Haemophilus influenzae: mechanisms, clinical importance and consequences for therapy.

Authors:  R de Groot; G Dzoljic-Danilovic; B van Klingeren; W H Goessens; H J Neyens
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

5.  Trimethoprim and rifampin in combination for chemoprophylaxis of household contacts of patients with invasive infections due to Haemophilus influenzae type b.

Authors:  R S Daum; M P Glode; D Ambrosino; N Halsey; D A Goldmann; F J Mather; R Russell; J Kamon; M Murray; J D Band
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.